Literature DB >> 11375455

Silent myocardial ischaemia in patients with proved coronary artery disease: a comparison of diabetic and non-diabetic patients.

C J Ditchburn1, J A Hall, M de Belder, A Davies, W Kelly, R Bilous.   

Abstract

OBJECTIVE: To determine whether diabetic patients with coronary artery disease are more likely to experience silent myocardial ischaemia than subjects without diabetes.
SUBJECTS: Patients undergoing coronary angiography at a regional cardiothoracic unit, identified as having diabetes from the local district diabetic register/database.
DESIGN: The coronary angiograms and exercise treadmill tests of 100 diabetic and 100 non-diabetic patients who all had significant coronary artery disease and maximal effort exercise tests were reviewed. Patients were individually matched for age group, gender, severity of coronary artery disease, and indication for treadmill test. OUTCOME MEASURES: Significant coronary artery disease was defined as a stenosis of greater than 50% diameter in at least one of the major coronary artery segments. Exercise tests were graded as positive if the electrocardiographic (ECG) recording showed planar or downsloping ST segment depression of > or = 1 mm in more than two leads at 80 ms post J-point or if there was a blood pressure fall > or = 10 mm Hg after an initial rise. A negative exercise test was defined as one in which the subject experienced no pain, had no ECG changes after maximal effort and had a normal blood pressure response. Subjects who did not experience any form of typical angina-type pain during a positive exercise test were defined as having an episode of silent ischaemia. Patients with symptomatic ischaemia were those who experienced typical angina-type pain with accompanying ST segment changes. Patients with a negative exercise test were defined as having "undetermined ischaemia". This category included all those without ECG evidence of myocardial ischaemia during the exercise test (with or without accompanying chest pain).
RESULTS: In the diabetic patients, 34% had ECG evidence of silent ischaemia on treadmill testing compared with only 19% of the non-diabetic controls (p < 0.02).
CONCLUSIONS: This study shows that diabetic patients with proved coronary artery disease have a higher risk of developing silent myocardial ischaemia during exercise than non-diabetic patients.

Entities:  

Mesh:

Year:  2001        PMID: 11375455      PMCID: PMC1742075          DOI: 10.1136/pmj.77.908.395

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  10 in total

1.  Investigation of coronary artery disease in diabetes: is screening of asymptomatic patients necessary?

Authors:  J W Sayer; A D Timmis
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

2.  Coronary artery disease and diabetes.

Authors:  M K Rutter; S M Marshall; J M McComb
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

3.  Prevalence of asymptomatic myocardial ischaemia in diabetic subjects.

Authors:  M J Koistinen
Journal:  BMJ       Date:  1990-07-14

4.  Autonomic dysfunction and silent myocardial ischaemia on exercise testing in diabetes mellitus.

Authors:  D P Murray; T O'Brien; R Mulrooney; D J O'Sullivan
Journal:  Diabet Med       Date:  1990-08       Impact factor: 4.359

5.  How important is a history of chest pain in determining the degree of ischaemia in patients with angina pectoris?

Authors:  A A Quyyumi; C M Wright; L J Mockus; K M Fox
Journal:  Br Heart J       Date:  1985-07

6.  Prevention of serious cardiac events by low-dose aspirin in patients with silent myocardial ischaemia. The Research Group on Instability in Coronary Artery Disease in Southeast Sweden.

Authors:  I Nyman; H Larsson; L Wallentin
Journal:  Lancet       Date:  1992-08-29       Impact factor: 79.321

7.  Silent myocardial ischaemia in patients with angiographically proven coronary artery disease.

Authors:  S N Sharma; R Bajaj; U Kaul; H S Wasir
Journal:  Indian Heart J       Date:  1989 May-Jun

8.  Identification of a high risk subgroup of patients with silent ischaemia after myocardial infarction: a group for early therapeutic revascularisation?

Authors:  M de Belder; D Skehan; C Pumphrey; B Khan; S Evans; M Rothman; P Mills
Journal:  Br Heart J       Date:  1990-03

9.  Silent myocardial ischaemia in chronic stable angina: a study of its frequency and characteristics in 150 patients.

Authors:  D Mulcahy; J Keegan; P Crean; A Quyyumi; L Shapiro; C Wright; K Fox
Journal:  Br Heart J       Date:  1988-11

10.  Silent myocardial ischemia in diabetics with normal autonomic function.

Authors:  G Ahluwalia; P Jain; S K Chugh; H S Wasir; U Kaul
Journal:  Int J Cardiol       Date:  1995-02       Impact factor: 4.164

  10 in total
  7 in total

1.  Characterization of upper thoracic spinal neurons receiving noxious cardiac and/or somatic inputs in diabetic rats.

Authors:  Marie Louise M Ghorbani; Chao Qin; Mingyuan Wu; Jay P Farber; Majid Sheykhzade; Bjarne Fjalland; Niels C B Nyborg; Robert D Foreman
Journal:  Auton Neurosci       Date:  2011-09-08       Impact factor: 3.145

2.  Painless myocardial ischemia is associated with mortality in patients with chronic kidney disease.

Authors:  James B Wetmore; Mike Broce; Amer Malas; Ammar Almehmi
Journal:  Nephron Clin Pract       Date:  2013-03-01

3.  Silent myocardial ischemia is associated with autonomic neuropathy and other cardiovascular risk factors in type 1 and type 2 diabetic subjects, especially in those with microalbuminuria.

Authors:  Ana Chico; Antoni Tomás; Anna Novials
Journal:  Endocrine       Date:  2005-08       Impact factor: 3.925

4.  The impact of diabetes on one-year health status outcomes following acute coronary syndromes.

Authors:  Pamela N Peterson; John A Spertus; David J Magid; Fredrick A Masoudi; Kimberly Reid; Richard F Hamman; John S Rumsfeld
Journal:  BMC Cardiovasc Disord       Date:  2006-10-24       Impact factor: 2.298

5.  The Degree of Diabetic Retinopathy in Patients with Type 2 Diabetes Correlates with the Presence and Severity of Coronary Heart Disease.

Authors:  Taewoong Um; Dong Hoon Lee; Joon-Won Kang; Eun Young Kim; Young Hee Yoon
Journal:  J Korean Med Sci       Date:  2016-06-03       Impact factor: 2.153

6.  Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?

Authors:  Guntram Schernthaner; Chaim Lotan; Elina Baltadzhieva-Trendafilova; Jonas Ceponis; Martin Clodi; Kristine Ducena; Eva Goncalvesova; Cristian Guja; Marek Honka; Andrej Janež; Nebojša Lalić; Roger Lehmann; Noémi Nyolczas; Priit Pauklin; Andrzej Rynkiewicz; Igor Sergienko; Lea Smirčić Duvnjak
Journal:  Cardiovasc Diabetol       Date:  2018-11-21       Impact factor: 9.951

7.  Predictive factors of late venous aortocoronary graft failure: ultrastructural studies.

Authors:  Bartlomiej Perek; Agnieszka Malinska; Sebastian Stefaniak; Danuta Ostalska-Nowicka; Marcin Misterski; Maciej Zabel; Anuj Suri; Michal Nowicki
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.